skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 79  for All Library Resources

Results 1 2 3 4 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Breast cancer: The translation of big genomic data to cancer precision medicine
Material Type:
Article
Add to My Research

Breast cancer: The translation of big genomic data to cancer precision medicine

Cancer science, 2018-03, Vol.109 (3), p.497-506 [Peer Reviewed Journal]

2017 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13463 ;PMID: 29215763

Full text available

2
Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK‐rearranged non–small cell lung cancer
Material Type:
Article
Add to My Research

Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK‐rearranged non–small cell lung cancer

Cancer science, 2022-11, Vol.113 (11), p.3888-3900 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15529 ;PMID: 35950895

Full text available

3
Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy
Material Type:
Article
Add to My Research

Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy

Molecular oncology, 2020-08, Vol.14 (8), p.1719-1730 [Peer Reviewed Journal]

2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1574-7891 ;EISSN: 1878-0261 ;DOI: 10.1002/1878-0261.12727 ;PMID: 32449983

Full text available

4
Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer
Material Type:
Article
Add to My Research

Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer

Cancer science, 2024-06, Vol.115 (6), p.1989-2001 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16149 ;PMID: 38531808

Full text available

5
Clinical implementation and current advancement of blood liquid biopsy in cancer
Material Type:
Article
Add to My Research

Clinical implementation and current advancement of blood liquid biopsy in cancer

Journal of human genetics, 2021-09, Vol.66 (9), p.909-926 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to The Japan Society of Human Genetics. ;The Author(s), under exclusive licence to The Japan Society of Human Genetics 2021. ;ISSN: 1434-5161 ;EISSN: 1435-232X ;DOI: 10.1038/s10038-021-00939-5 ;PMID: 34088974

Full text available

6
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?
Material Type:
Article
Add to My Research

Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?

Clinical chemistry (Baltimore, Md.), 2020-07, Vol.66 (7), p.946-957 [Peer Reviewed Journal]

American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2020 ;American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;COPYRIGHT 2020 American Association for Clinical Chemistry, Inc. ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1093/clinchem/hvaa103 ;PMID: 32516802

Full text available

7
Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer
Material Type:
Article
Add to My Research

Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer

Cancer science, 2021-01, Vol.112 (1), p.454-464 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14697 ;PMID: 33075187

Full text available

8
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer
Material Type:
Article
Add to My Research

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer

Cancer science, 2022-05, Vol.113 (5), p.1808-1820 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15304 ;PMID: 35201661

Full text available

9
A genome-wide association study in the Japanese population confirms 9p21 and 14q23 as susceptibility loci for primary open angle glaucoma
Material Type:
Article
Add to My Research

A genome-wide association study in the Japanese population confirms 9p21 and 14q23 as susceptibility loci for primary open angle glaucoma

Human molecular genetics, 2012-06, Vol.21 (12), p.2836-2842 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0964-6906 ;EISSN: 1460-2083 ;DOI: 10.1093/hmg/dds103 ;PMID: 22419738

Full text available

10
Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations
Material Type:
Article
Add to My Research

Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations

Cancer science, 2019-03, Vol.110 (3), p.867-874 [Peer Reviewed Journal]

2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13919 ;PMID: 30582659

Full text available

11
The road map of cancer precision medicine with the innovation of advanced cancer detection technology and personalized immunotherapy
Material Type:
Article
Add to My Research

The road map of cancer precision medicine with the innovation of advanced cancer detection technology and personalized immunotherapy

Japanese journal of clinical oncology, 2019-07, Vol.49 (7), p.596-603 [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyz073 ;PMID: 31135897

Full text available

12
Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer
Material Type:
Article
Add to My Research

Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer

Breast cancer research and treatment, 2020-04, Vol.180 (2), p.331-341 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2020 ;COPYRIGHT 2020 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2020). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-019-05512-5 ;PMID: 32020432

Full text available

13
Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges
Material Type:
Article
Add to My Research

Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges

Cancers, 2022-07, Vol.14 (13), p.3275 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers14133275 ;PMID: 35805046

Full text available

14
Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
Material Type:
Article
Add to My Research

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients

Frontiers in oncology, 2023-01, Vol.12, p.1055968-1055968 [Peer Reviewed Journal]

Copyright © 2023 Chan, Nagayama, Otaki, Chin, Fukunaga, Ueno, Nakamura and Low. ;Copyright © 2023 Chan, Nagayama, Otaki, Chin, Fukunaga, Ueno, Nakamura and Low 2023 Chan, Nagayama, Otaki, Chin, Fukunaga, Ueno, Nakamura and Low ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2022.1055968 ;PMID: 36776372

Full text available

15
Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA
Material Type:
Article
Add to My Research

Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA

Human molecular genetics, 2012-05, Vol.21 (9), p.2102-2110 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0964-6906 ;EISSN: 1460-2083 ;DOI: 10.1093/hmg/dds020 ;PMID: 22286173

Full text available

16
Genome-wide association meta-analysis identifies new endometriosis risk loci
Material Type:
Article
Add to My Research

Genome-wide association meta-analysis identifies new endometriosis risk loci

Nature genetics, 2012-12, Vol.44 (12), p.1355-1359 [Peer Reviewed Journal]

2014 INIST-CNRS ;COPYRIGHT 2012 Nature Publishing Group ;COPYRIGHT 2012 Nature Publishing Group ;Copyright Nature Publishing Group Dec 2012 ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/ng.2445 ;PMID: 23104006 ;CODEN: NGENEC

Full text available

17
GWAS of five gynecologic diseases and cross-trait analysis in Japanese
Material Type:
Article
Add to My Research

GWAS of five gynecologic diseases and cross-trait analysis in Japanese

European journal of human genetics : EJHG, 2020-01, Vol.28 (1), p.95-107 [Peer Reviewed Journal]

2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 1018-4813 ;EISSN: 1476-5438 ;DOI: 10.1038/s41431-019-0495-1 ;PMID: 31488892

Full text available

18
Clinical characteristics of patients with KRAS mutation detected by liquid biopsy
Material Type:
Article
Add to My Research

Clinical characteristics of patients with KRAS mutation detected by liquid biopsy

Thoracic cancer, 2023-11, Vol.14 (33), p.3317-3322 [Peer Reviewed Journal]

2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1759-7706 ;EISSN: 1759-7714 ;DOI: 10.1111/1759-7714.15123

Full text available

19
Genome‐wide association study of chemotherapeutic agent‐induced severe neutropenia/leucopenia for patients in Biobank Japan
Material Type:
Article
Add to My Research

Genome‐wide association study of chemotherapeutic agent‐induced severe neutropenia/leucopenia for patients in Biobank Japan

Cancer science, 2013-08, Vol.104 (8), p.1074-1082 [Peer Reviewed Journal]

2013 Japanese Cancer Association ;2013 Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.12186 ;PMID: 23648065

Digital Resources/Online E-Resources

20
Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy
Material Type:
Article
Add to My Research

Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy

Cancers, 2021-09, Vol.13 (19), p.4803 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers13194803 ;PMID: 34638288

Full text available

Results 1 - 20 of 79  for All Library Resources

Results 1 2 3 4 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (68)

Refine My Results

Creation Date 

From To
  1. Before 2010  (4)
  2. 2010 To 2012  (8)
  3. 2013 To 2015  (8)
  4. 2016 To 2019  (20)
  5. After 2019  (40)
  6. More options open sub menu

Searching Remote Databases, Please Wait